Market Research

Insurance and insurtech research: a build vs buy framework and screener

A decision framework and screener for insights leaders choosing how to run insurance and insurtech research with verified underwriters, brokers, and claims experts.

CleverX Team ·
Insurance and insurtech research: a build vs buy framework and screener

If you are deciding how to run an insurance or insurtech study, use the build vs buy framework and screener in this post to make the call in an afternoon and field verified underwriters, brokers, claims, and risk leaders within days. For almost every insurance insights team the answer is buy on-demand access to verified professionals rather than build a panel, because the population is regulated, specialized, and expensive to recruit and re-verify. The framework below scores that decision for your exact context.

A note on fairness and accuracy: This comparison is based on publicly available information and secondary research. Vendors update their pricing, features, and positioning over time, so please confirm the current details with each provider directly before you decide. We aim to be objective and fair. Every company covered here is a strong option in the space, and the best choice depends on your specific needs.

Book a demo with CleverX to see how fast you can reach verified insurance and insurtech professionals.

Insurance research is hard in a specific way. The people you need, underwriters, actuaries, brokers, and claims adjusters, sit behind strict compliance policies, work in technical categories, and almost never respond to cold outreach. Industry bodies like the National Association of Insurance Commissioners and the Insurance Information Institute document how regulated and segmented the market is, and Deloitte’s insurance industry outlook shows how fast insurtech is reshaping product and distribution. That combination of regulation, technical depth, and change is exactly why the build vs buy decision deserves a framework rather than a gut call.

For the audience-level grounding on who these buyers are and how to reach them, our companion guide on B2B insurance and insurtech market research maps the roles in detail. This post is the buying decision: how you run the study, and with whom.

The build vs buy decision framework

Score your situation against the framework below. For each row, decide whether your reality points toward build or buy, then count. If you land on build for five or more rows, building a panel may pay off. For almost everyone else, buying wins. Our broader enterprise build vs buy framework carries the full cost math, and the developer and legal editions in this series apply the same logic to their verticals.

FactorPoints to BUILDPoints to BUY
Study volumeMore than 30 insurance studies a yearBursts tied to product milestones
Time to usable panelYou can fund 12 to 24 months of recruitingYou need respondents in days
Re-verification burdenYou can re-verify roles and licensing continuouslyYou want verification handled for you
Attrition toleranceYou can manage 20 to 30 percent annual churnYou cannot carry panel maintenance
Compliance capacityLegal owns consent and data handling in-houseYou want a partner to carry compliance load
Reach beyond your baseYou only need your own customersYou need prospects, switchers, and multi-region reach
Cost modelYou want fixed capability and low marginal costYou want variable per-study spend

The honest reading is that insurance pushes most teams toward buy. The population is small and specialized, licensing and roles change, and continuous re-verification is a real operational cost. A panel you build in insurance decays faster than in most verticals, which is why the framework weights the re-verification and compliance rows so heavily.

Why verification is the whole game in insurance

Insurance decisions touch pricing, reserving, and product strategy, so a wrong read is expensive. That raises the stakes on who actually answers your study. The most common way insurance data gets corrupted is misrepresentation: a respondent overstates seniority or line of business to collect an incentive. The ESOMAR and GRBN standards on sample quality make the same point that applies doubly here, that without identity assurance, sample is just traffic.

This is the real hidden cost. The money you save on a cheaper, unverified complete is trivial next to the cost of a flawed pricing or product decision made on bad data. When you run the framework, treat verification capacity as a gate, not a line item: if you cannot verify employment and role at scale yourself, that alone points you toward buy.

The insurance research screener you can lift

Verification confirms a real person in a real job. The screener confirms they are right for this study. Here is a reusable opener for insurance audiences. For the broader mechanics, see research participant screener best practices.

INSURANCE SCREENER (first five questions)

Q1. Which best describes your current role?
    - Underwriter                        [continue]
    - Broker / agent                     [continue]
    - Claims adjuster / claims leader    [continue]
    - Actuary / risk / compliance leader [continue]
    - None of the above                  [disqualify]

Q2. Which line of business do you primarily work in?
    [single select; must match target: P&C, life, health,
     commercial, specialty, reinsurance]

Q3. What is your role in evaluating insurtech or software tools?
    - I decide                 [budget holder]
    - I influence the decision [influencer]
    - I am an end user only     [route per quota]

Q4. [Knowledge check] Which of the following best describes
    [a line-specific concept only a practitioner would know,
     e.g. loss ratio, combined ratio, reserving]?
    [correct answer required to continue]

Q5. Would participating require disclosing confidential
    policyholder or claims information?
    - Yes  [disqualify or re-scope]
    - No   [continue]

Q4 keeps out non-practitioners who selected a role to qualify, and Q5 protects both the respondent and your compliance posture. Calibrate the knowledge check to the line of business using references like the resources from The Institutes, which set the professional standards for much of the industry. Our guides on recruiting insurance agents and brokers for insurtech research and recruiting compliance and risk officers for regtech research go deeper on role-specific screening.

The done-for-you path when you land on buy

If the framework points you to buy, the goal is verified supply that removes both the recruiting lead time and the verification burden. CleverX gives you on-demand access to more than 10 million verified B2B and B2C professionals across 150 plus countries, including underwriters, brokers, claims professionals, actuaries, and risk and compliance leaders. Every professional is verified against work email, employer, and job title, which is the gate that makes the insurance screener above trustworthy.

Because the supply is already verified, teams typically field a focused insurance study and see results in days rather than the two to four weeks a traditional agency or cold recruitment takes. That speed is the practical reason buy beats build for most insurance teams: you spend your effort on strategy and analysis, not on proving respondents are who they claim to be. When speed is the binding constraint, our B2B speed recruitment playbook shows how to compress the timeline further.

Book a demo with CleverX to scope an insurance or insurtech study against your exact line of business and seniority criteria.

Matching method to the insurance decision

The method should follow the decision.

Moderated interviews suit discovery, workflow mapping, and claims-experience research, where you need to probe how an underwriter or adjuster actually works. Plan for 8 to 12 interviews per segment, such as commercial underwriters versus personal-lines brokers, to reach saturation.

Unmoderated usability tests suit insurtech product flows, quoting tools, and claims portals, where you watch practitioners attempt real tasks.

Surveys at scale suit pricing, feature prioritization, and market sizing across lines of business. Small, high-value insurance populations make verified sample essential, which is why statistical confidence and verification have to travel together.

A strong partner lets you run all three against the same verified supply, so you can move from a qualitative signal to a quantitative confirmation without rebuilding your audience.

Reading the framework when you are a hybrid

Most mature insurance insights functions do not land on a pure build or a pure buy. They build in-house capability where institutional knowledge compounds, namely strategy, questionnaire design, and analysis, and they buy recruitment and fieldwork where scale, speed, and reach are the constraints. The framework above is still the right tool for the hybrid case, because the rows that point to buy, re-verification burden, compliance capacity, reach beyond your base, and variable cost, are almost always the operational rows, not the strategic ones.

In practice that means your team owns the research questions and the interpretation, and a verified-supply partner owns getting the right underwriters, brokers, and claims leaders in front of you. This keeps insight ownership internal, which matters in a regulated category where you need to defend how a finding was produced, while removing the parts of the process that would otherwise slow a two-week study to a two-month one.

The hybrid also future-proofs the program. Insurtech moves fast, and the roles you need shift as new lines, channels, and tools emerge. A fixed panel ages out of relevance, but on-demand access to a continuously verified pool lets you retarget each study to whoever the current decision actually requires, without carrying the maintenance cost between studies.

Common mistakes in insurance and insurtech research

  • Treating “insurance professional” as one segment. An underwriter, a broker, and a claims adjuster make different decisions. Segment by role and line of business.
  • Skipping the compliance question. If a study could require disclosure of confidential policyholder data, re-scope it before fielding, not after.
  • Trusting self-reported roles. Self-report invites misrepresentation in a high-incentive category. Verify employer and title against professional identity.
  • Underpricing specialized respondents. Senior insurance professionals command higher incentives than consumer respondents, and underpricing them tanks response.
  • Building a panel you cannot maintain. Licensing and roles change. If you cannot re-verify continuously, the framework is telling you to buy.

McKinsey’s work on the future of insurance underlines how quickly product and distribution are shifting, which is another reason to favor flexible, on-demand access over a fixed panel that ages out of relevance.

Make the call this week

Insurance and insurtech research rewards teams that decide how to run the study before they design it. The framework above turns a gut call into a scored decision, and for most insights leaders it points the same way: buy verified access, keep strategy and analysis in-house, and let a partner carry verification and compliance. The screener gives you a fielding-ready starting point, and the two-week turnaround becomes realistic once the supply is already verified.

If you need verified underwriters, brokers, claims, and risk leaders fast, that is what CleverX is built for: 10 million plus verified professionals, 150 plus countries, and results in days instead of weeks.

Book a demo with CleverX and bring your insurance research brief.

Frequently asked questions

Should we build an insurance research panel or buy access?

Most insurance insights teams should buy on-demand access to verified underwriters, brokers, claims, and risk professionals rather than build a panel, because the population is specialized, regulated, and expensive to recruit and re-verify. Building only pays off at very high study volumes where the panel is a strategic asset and you can fund continuous recruitment, re-verification, and compliance management. The framework in this post scores the decision for your context.

What makes insurance and insurtech research different?

Insurance research reaches regulated, hard-to-access professionals like underwriters, brokers, actuaries, and claims adjusters who sit behind compliance policies and rarely answer cold outreach. The categories are technical, data handling is sensitive, and misrepresentation is costly because a wrong read on underwriting appetite or claims behavior can affect pricing and reserves. Verified identity and role, plus compliant data handling, matter more here than in general B2B research.

How do you screen insurance professionals for research?

Verify current role, line of business, carrier or brokerage setting, seniority, and licensing where relevant, then add a knowledge check that only a practitioner could answer and a disqualifier for conflicted respondents. Verifying employer and job title against professional identity, rather than trusting self-report, is what keeps non-practitioners and incentive-seekers out of a high-value insurance sample.

How fast can you run an insurance research study?

With a partner that already holds verified insurance professionals, you can field a focused study and complete the first interviews within days, compared with the two to four weeks a traditional agency or cold recruitment usually takes. Verified supply is the biggest lever on speed, because you are not spending the first two weeks proving respondents are who they claim to be.

What is the biggest hidden cost in insurance research recruitment?

Misrepresentation. Unverified panels let respondents overstate seniority or line of business to collect incentives, which corrupts data in a category where decisions touch pricing, reserving, and product strategy. The real hidden cost is the flawed business decision made on bad data, so employment and role verification is worth more than a lower sticker price per complete.

How do you stay compliant when researching insurance professionals?

Use clear consent language, avoid asking respondents to disclose confidential policyholder or claims data, anonymize and store responses according to regional obligations, and screen out conflicted or regulated-disclosure situations up front. Working with a partner that handles verification and consent, and that can reach professionals across regions, reduces the compliance burden on your internal team.